Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

United Therapeutics Corporation - Common Stock (NQ:UTHR)

469.05 +2.65 (+0.57%)
Streaming Delayed Price Updated: 1:59 PM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about United Therapeutics Corporation - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
News headline image
United Therapeutics Corporation to Present at the Oppenheimer 33rd Annual Healthcare Conference
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Corporation to Present at the Cowen 43rd Annual Health Care Conference
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2022 Financial Results
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2022 Financial Results Before the Market Opens on Wednesday, February 22, 2023
From United Therapeutics Corporation
Via Business Wire
Analyst Ratings for United Therapeutics ↗
 
Via Benzinga
Morgan Stanley Maintains Overweight Rating for United Therapeutics: Here's What You Need To Know ↗
 
Via Benzinga
Expert Ratings for United Therapeutics ↗
 
Via Benzinga
6 Analysts Have This to Say About United Therapeutics ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 22, 2023 ↗
Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022. 
Via Benzinga
News headline image
Earnings Outlook For United Therapeutics ↗
 
Via Benzinga
News headline image
Want To Copy 'Master Trader' Nancy Pelosi's Investments? There's An ETF For That. Here Are The Holdings ↗
Subversive Capital launched two new ETFs Tuesday that offer investors the chance to mirror the trades being made by members of Congress. 
Via Benzinga
News headline image
3 Biotech Companies to Watch in 2023 ↗
These biotech companies to watch are remarkably strong businesses that offer healthy upside potential as we head into a new year. 
Via InvestorPlace
News headline image
Crocs, Lamb Weston And These 3 Stocks Insiders Are Selling ↗
The Nasdaq Composite dropped around 150 points on Thursday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
News headline image
Alphabet And These 2 Healthcare Stocks Insiders Are Selling ↗
The Nasdaq Composite dropped around 80 points on the first trading day of 2023. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
News headline image
United Therapeutics Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference
From United Therapeutics Corporation
Via Business Wire
News headline image
Should SMLF Be On Your Investing Radar? ↗
Sitting at a market capitalization below $2 billion, small cap companies tend to be high-potential stocks compared to their large and mid-cap counterparts but come with higher risks. 
Via Talk Markets
News headline image
Buy/Sell: Wall Street's Top 10 Stock Calls This Week - Saturday, Dec. 10 ↗
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street’s best analysts during the week of Dec. 5-9, 2022. 
Via Talk Markets
News headline image
Our 7 Top Biotech Stock Picks for 2023 ↗
Following the devastation of Covid-19, there’s greater interest toward medical innovations, thus bolstering biotech stock picks for 2023. 
Via InvestorPlace
News headline image
United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2023
From United Therapeutics Corporation
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022 ↗
 
Via Benzinga
News headline image
United Therapeutics, Super Micro Computer, Novo Nordisk And Other Big Gainers From Wednesday ↗
U.S. stocks closed lower on Wednesday, with the Dow Jones dropping more than 500 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For December 5, 2022 ↗
 
Via Benzinga
News headline image
Recap: United Therapeutics Q3 Earnings ↗
United Therapeutics (NASDAQ:UTHR) reported its Q3 earnings results on Wednesday, November 2, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday ↗
Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results. 
Via Benzinga
News headline image
Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results. 
Via Benzinga
News headline image
United Therapeutics Corporation Reports Third Quarter 2022 Financial Results
From United Therapeutics Corporation
Via Business Wire
News headline image
Earnings Scheduled For November 2, 2022 ↗
Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for its second quarter. 
Via Benzinga
News headline image
United Therapeutics Corporation to Present at the Credit Suisse 31st Annual Healthcare Conference
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Posts Data From Remodulin Induction Before Orenitram Therapy In High Blood Pressure Patients ↗
 
Via Benzinga
News headline image
United Therapeutics Announces Top Line Data From the EXPEDITE Study of Remodulin Induction Prior to Orenitram Therapy
From United Therapeutics Corporation
Via Business Wire
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.